Our results show that women diagnosed in the first year after delivery more often had adverse tumour characteristics, e.g. advanced stage, ER negativity, higher grade, and more often HER2-positive and TNBC subtypes than women diagnosed not near pregnancy, with stronger associations within the first 9 months of delivery. Here, ERBB2 is linked to neoplasm.